Cargando…
Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling
ADAM10 (A Disintegrin and Metalloprotease Domain 10) affects the pathophysiology of various cancers, and we had shown that inhibition of ADAM10 sensitizes pancreatic cancer cells to gemcitabine. ADAM10 is activated in response to calcium influx, and here we examined if calcium channel blockers (CCB)...
Autores principales: | Woods, Neha, Trevino, Jose, Coppola, Domenico, Chellappan, Srikumar, Yang, Shengyu, Padmanabhan, Jaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742152/ https://www.ncbi.nlm.nih.gov/pubmed/26440150 |
Ejemplares similares
-
Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
por: Alhothali, Marwa, et al.
Publicado: (2019) -
The Role of nAChR and Calcium Signaling in Pancreatic Cancer Initiation and Progression
por: Schaal, Courtney, et al.
Publicado: (2015) -
A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis
por: Bora-Singhal, Namrata, et al.
Publicado: (2022) -
Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment
por: Brizzolara, Antonella, et al.
Publicado: (2020) -
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
por: Singh, Sandeep, et al.
Publicado: (2012)